A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
|Articles|August 23, 2006
Why Cytyc Bought Novacept Video
Author(s)OBGYN.net Staff
OBGYN.net Conference Coverage - AAGL 2004
Advertisement
Press Release:
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of RealPlayer, available
Advertisement
Related to this article
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.
Before prescribing testosterone, know what the evidence actually proves. Maria Uloko, MD, draws a sharp line between the one population the data supports and the much wider group of women asking about it.
Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.
David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA holding public meeting on testosterone use in menopausal women
2
Pellet therapy and practical advice for hesitant prescribers
3
Reviewing the evidence about testosterone in women
4
Earlier menopause associated with less favorable functional, structural neurological outcomes
5